StockVS

HCM IV Acquisition Corp. (HACQU) Analyse boursière

Services Financiers

HCM IV Acquisition Corp.

$10.07

+$0.00 (+0.00%)

Dernière mise à jour : 26 mai 2026

Historique des Prix

Analyse

Présentation de l'entreprise

HCM IV Acquisition Corp. (HACQU) operates as a special purpose acquisition company, or SPAC, dedicated to effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The entity functions within the Financial Services sector, specifically categorized under the industry of Shell Companies, a designation that implies the organization currently has no independent business operations and exists solely to facilitate a future merger transaction. The company's scale is defined by a market capitalization and annual revenue that are both listed as N/A, alongside an employee count also recorded as N/A, reflecting its pre-merger status as a shell entity. These specific valuation figures indicate that the company is not yet a standalone operating business with established revenue streams or a traditional market cap based on operational earnings, but rather a vehicle whose value is contingent upon the completion of a pending business combination and the subsequent valuation of the target assets.

Santé financière

The financial performance of HCM IV Acquisition Corp. shows a Net Income (TTM) of $-178,965, while Revenue (TTM) and EBITDA are both listed as N/A, highlighting the typical financial profile of a pre-transaction SPAC where operating expenses have been incurred without corresponding revenue generation. The gap between the reported net income loss and the absence of revenue data reveals a cost structure composed entirely of organizational overhead, filing fees, and sponsor costs incurred prior to any commercial activity or merger completion. Free Cash Flow is listed as N/A, which signifies that the company has not yet generated operational cash flows to fund capital expenditures or working capital needs, relying instead on trust account proceeds or equity financing. The analysis of margins shows a Gross Margin of 0.0%, an Operating Margin of 0.0%, and a Profit Margin of 0.0%, indicating that the company has not yet achieved any revenue scale to realize gross profit or operational leverage. Regarding liquidity and leverage, the company reports a Debt level of $0, contrasting with a Cash position listed as N/A, resulting in a Debt to Equity ratio that is N/A and a Current Ratio of 0.13. The current ratio of 0.13 indicates a constrained short-term liquidity position where current liabilities significantly exceed current assets, a common characteristic for SPACs that have spent down initial capital on administrative costs. Return on Equity and Return on Assets are both listed as N/A, meaning that management effectiveness cannot yet be measured by traditional return metrics due to the lack of positive earnings and established asset bases.

Évaluation de la valorisation

The trailing P/E Ratio (TTM) and Forward P/E are both listed as N/A, which implies that traditional earnings-based valuation metrics are not applicable to a company with no positive earnings or revenue history, rendering comparisons of expected earnings trajectories irrelevant at this stage. The Price to Book ratio is reported at -2505.00, a negative figure that indicates the market capitalization is valued significantly below the company's net asset value, or conversely, reflects a valuation anomaly where the book value calculation results in a negative multiple due to the accumulated losses and lack of tangible asset backing relative to the stock price. The Price to Sales ratio and EV/EBITDA are both listed as N/A, suggesting that alternative valuation metrics relying on revenue multiples or enterprise value multiples are currently unavailable or meaningless without active sales or EBITDA generation. The stock has traded between a 52-Week High of $10.15 and a 52-Week Low of $10.02, placing the current trading range in a highly compressed band that suggests limited price discovery and volatility typical of shell companies awaiting a target. The Beta is listed as N/A, meaning that the company's price volatility relative to the broader market cannot be quantified yet as the stock price moves primarily on merger speculation rather than fundamental market correlations.

Growth & Income

Revenue Growth (YoY) and Earnings Growth (YoY) are both listed as N/A, which precludes any analysis of growth rates or the ability to determine whether earnings are growing faster or slower than revenue, as the company has not yet established a historical revenue base. Since the company is not a dividend payer, the Dividend Yield and Payout Ratio are both listed as N/A, indicating that the company does not distribute cash to shareholders and instead retains capital for potential transaction costs or the future business combination. Consequently, the company reinvests all available resources into the pursuit of a merger target rather than paying dividends, as is standard practice for SPACs in the pre-completion phase. The overall growth and income profile is characterized by the absence of historical performance data, with all growth and income metrics currently unavailable until a target business is identified and integrated into the combined entity.

Comparaison avec les pairs

HCM IV Acquisition Corp. (HACQU) opère dans le secteur Sociétés Écrans. Voici comment il se compare à ses pairs les plus proches par capitalisation boursière :

Entreprise Ticker Cap. Boursière Ratio P/E
HCM IV Acquisition Corp. HACQU N/A N/A
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

Le ratio P/E moyen du secteur Sociétés Écrans est de 82.8x. HCM IV Acquisition Corp. se négocie à un P/E de N/A.

Cette analyse est générée par IA à titre informatif uniquement et ne constitue pas un conseil financier. Les données peuvent être retardées ou inexactes. Faites toujours vos propres recherches et consultez un conseiller financier qualifié avant de prendre des décisions d'investissement.

À propos de HCM IV Acquisition Corp.

HCM IV Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was incorporated in 2025 and is based in Stamford, Connecticut.

La description de l'entreprise est affichée en anglais.

Statistiques Clés

Capitalisation
N/A
Ratio P/E
N/A
Plus Haut 52 Sem.
$10.15
Plus Bas 52 Sem.
$10.01
Volume Moyen
8.65K

Données fournies par Yahoo Finance via yfinance. Mis à jour quotidiennement.

Info Entreprise

Bourse
NASDAQ
Pays
United States